Pharmazac launched the new product Apregalin® / pregabalin

Pharmazac launched the new product Apregalin® / pregabalin for the treatment of peripheral and central neuropathic pain in adults, for epilepsy as adjunctive therapy in adults with partial seizures with or without secondary generalization and for the Generalized Anxiety Disorder in adults.